Stock traders scrambled to acquire a piece of Stereotaxis, Inc. (NASDAQ:STXS) following Monday's post-market announcement that the company had received FDA clearance to market its Vdrive™ Robotic Navigation System with V-Sono™ Intracardiac Echocardiography (ICE) catheter manipulator in the U.S. The company has had success with the Vdrive system in Europe over the past few years, and is likely to do the same here in America, as investors lined up this morning the stock traded considerable pre-market volume.

The Vdrive system involves highly technical medical technology, but we'll try to break it down as simply as possible. Basically, when performing highly complex procedures, electrophysiologists use several specialized diagnostic catheters and positioning sheaths. Managing and navigating these devices is a large part of the workload for these kinds of procedures, which is where the Vdrive system comes into play. It has, through extensive use in Europe beginning in 2011, been proven to improve the efficiency of such procedures by a significant margin.

Our subscribers would have had the opportunity for significant gains if they had caught STXS's appearance in this morning's extended watchlist. The stock is changing hands at a rapid pace, having jumped out of the gate in the low 2.30's, and as of 11:02AM, hitting a high of 6.90. If you aren't already signed up for our free daily alerts, we suggest you do so now, as they often contain winning picks of this magnitude and greater.

Stereotaxis, Inc. (STXS) is definitely going to be a stock to keep an eye on moving forward as they begin to introduce the Vdrive system to the domestic market.
 

Check back often for more articles, news,  insights, tips, and picks, right here at Bull in Advantage. Be sure to SIGN UP FOR OUR DAILY REPORTS, and stay up to date on everything that catches our interest. Happy Trading to All, and Good Luck out there!